Enovix CorporationENVXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+23.7%
5Y CAGR+50.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+23.7%/yr
Annual compound
5Y CAGR
+50.1%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
7.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$109.92M-11.7%
2024$124.51M+40.9%
2023$88.39M+52.3%
2022$58.05M+53.4%
2021$37.85M+162.1%
2020$14.44M+18.9%
2019$12.15M-